Scientific publications 

The impact of deep brain stimulation on executive function in Parkinson's disease

M. Jahanshahi (1,2), C. M. A. Ardouin (3), R. G. Brown (2), J. C. Rothwell (2), J. Obeso (5), A. Albanese (6), M. C. Rodríguez-Oroz (5), E. Moro (4), A. L. Benabid (3), P. Pollak (3) and P. Limousin-Dowsey (2)
(1) Department of Clinical Neurology, Institute of Neurology
(2) MRC Human Movement and Balance Unit, The National Hospital for Neurology and Neurosurgery, London
(3) Neuroscience Department, Grenoble France,
(4) Functional Neurology and Neurosurgery Center, Clínica Quirón, San Sebastián
(5) Department of Neurology and Neurosurgery, Division of Neuroscience, Clínica Universitaria and Medical School, University of Navarra, Pamplona, Spain
(6) Universita Cattolica, Instituto di Neurologia, Rome, Italy

Magazine: Brain

Date: Jun 1, 2000

Neurology [SP]

Deep brain stimulation (DBS) of the subthalamic nucleus (STN) or the internal segment of the globus pallidus (GPi) improves Parkinson's disease and increases frontal blood flow.

We assessed the effects of bilateral DBS on executive function in Parkinson's disease patients, seven with electrodes implanted in the STN and six in the GPi. Patients were assessed off medication with stimulators off, on and off again. The groups showed differential change with stimulation on the Reitan Trail-Making test (TMT B) (STN more improved) and on some measures of random number generation and Wisconsin Card Sorting (STN improved, GPi worse with stimulation).

Across the groups, stimulation speeded up responding (Stroop control trial, TMT A) and improved performance on paced serial addition and missing digit tests. Conversely, conditional associative learning became more errorful with stimulation across the two groups. In general, change in performance with stimulation was significant for the STN but not the GPi group. These results support two opposite predictions. In support of current models of Parkinson's disease, 'releasing the brake' on frontal function with DBS improved aspects of executive function.

Conversely, disruption of basal ganglia outflow during DBS impaired performance on tests requiring changing behaviour in novel contexts as predicted by Marsden and Obeso in 1994.

CITATION  Brain. 2000 Jun;123 ( Pt 6):1142-54

you maybe interested

WHAT TECHNOLOGY
DO WE USE?

The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

OUR
PROFESSIONALS

The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

Imagen profesionales de la Clínica Universidad de Navarra

WHY CHOOSE
THE CLINICA?

Learn why we are different from other healthcare centers. Quality, speed, comfort and results.

Imagen del edificio de la Clínica Universidad de Navarra